INTRODUCTION
14-3-3σ is a family member of 14-3-3 proteins (14-3-3β, ε, θ/τ, ζ, σ, γ and η) in human and has been implicated in the development of cancer and in treatment resistance and poor prognosis (1) . While 14-3-3σ is thought to function as a tumor suppressor in mammary tissue, its expression has been found to up-regulate in drug resistant cancers of pancreas and breast and associates with poor prognosis (2-6). 14-3-3σ has also been found recently to regulate invasion of breast cancer cells (7) and EMT (8) , which may contribute to poor cancer prognosis.
At the molecular level, 14-3-3σ was though to protect cancer cells against genotoxic treatments by regulating cell cycle progression and survival pathways (9, 10) . Somatic 14-3-3σ knockout led to mitotic catastrophe upon DNA damages (9) . Following DNA damage, 14-3-3σ-sufficient cells are able to arrest in G2/M phase and survive while 14-3-3σ-deficient cells continue to progress through cell cycles and to cell death (11) . It, thus, has been postulated that 14-3-3σ contributes to survival and DNA-damage resistance by arresting cells in G2/M phase (12) . However, the molecular mechanism of 14-3-3σ action in this process remains unknown.
Radiation therapy is an important component of cancer treatments. IR impairs the survival of cancer cells mainly by causing double strand breaks (DSBs) in the DNA backbone.
However, increased repair of DSBs would lead to IR resistance. Although DSBs are repaired by both homologous recombination (HR) and non-homologous end-joining (NHEJ) mechanisms, the latter directly ligates two DSB ends without the need of the template and, thus it functions throughout all phases of the cell cycle and is the predominant DSB repair pathway in mammalian cells while HR occurs mainly in mid-late S phases (13, 14) .
In this study, we tested the hypothesis that 14-3-3σ contributes to radiation resistance by up-regulating NHEJ repair while arresting cells in G2/M phase. We found that 14-3-3σ ectopic overexpression increased while its knockdown reduced IR resistance and NHEJ repair activity. We also showed that 14-3-3σ-induced increases in NHEJ repair activity was via up-regulating Chk2 and by increasing PARP1 expression via up-regulating its transcription and inhibiting caspase-mediated degradation of PARP1 protein. Furthermore, 14-3-3σ up-regulation of PARP1 increased DNA-PKcs recruitment to chromatin DNA, facilitating NHEJ repair of DSBs. These findings revealed an important molecular mechanism how 14-3-3σ contributes to chemo and radiation resistance and to poor prognosis of human cancers.
MATERIALS AND METHODS

Materials.
Antibodies against 14-3-3σ, Chk1, Chk2 and DNA-PKcs were from EMD Millipore (Billerica, MA). The γ-H2AX antibody was from Enzo Biochem (New York, NY).
14-3-3σ siRNA pool and antibodies against Ku70 and Ku80 were from Santa Cruz Biotechnology (Dallas, TX). PARP1 and histone H3 antibodies were from Cell Signaling Technology (Danvers, MA). Adriamycin, mitoxantrone, and antibodies against GAPDH, β-Actin and α-Tubulin were from Sigma-Aldrich (St. Louis, MO). G418, pcDNA3.1(+) plasmid, and SYBR Green polymerase chain reaction (PCR) master mix were from Applied Biosystems (Grand Island, NY). The iScript cDNA synthesis kit, metafectene Pro transfection reagent, and gemcitabine were from Bio-Rad (Hercules, CA), Biontex (München, Germany), and Besse Medical (West Chester, OH), respectively. All other chemicals were purchased from Sigma-Aldrich or Fisher Scientific (Waltham, MA).
Cell lines and transfections. BxPC-3 cells with stable 14-3-3σ knockdown or harboring scrambled shRNA control were generated in a previous study (2) and cultured in RPMI1640 supplemented with 10% fetal bovine serum. MiaPaCa-2 cells with stable overexpression of ectopic 14-3-3σ and the control cells harboring vector control were also generated in a previous study (2) and cultured in (DMEM) supplemented with 10% fetal 5 bovine serum and 2.5% horse serum. All cultures were at 37°C with 5% CO 2 . The cell lines were authenticated by analysis of tandem repeat sequences on 09/17/2013.
For transient knockdown, BxPC-3 cells were plated in 6-well plates at 2.0×10 5 cells/well and cultured overnight in complete media. About 60 pmol siRNAs targeting PARP1, Chk2, or control scrambled siRNA were diluted in serum-free RPMI1640 media and transiently transfected into cells using Metafectene Pro as previously described (15) . For transient knockdown of 14-3-3σ, pSilencer-σ or scrambled shRNA construct engineered in a previous study (11) was transfected into BxPC-3 cells using Metafectene Pro transfection reagent as previously described (15) . The sequences of siRNAs are shown in Supplemental   Table S1 .
Cytotoxicity assay. Cytotoxicity was determined using MTT and colony formation assays as previously described (2, 16) . MTT assay was used to determine cytotoxicity of anticancer drugs. Briefly, cells were seeded in 96-well plate at 3000 cells/well and cultured for 24 hrs followed by treatment with anticancer drugs and cultured continuously for 72 hrs at 37°C. Then, MTT (5 mg/mL) was added to the culture and incubated for another 4 hrs. The culture medium was then aspirated followed by addition of DMSO and absorption was determined using a 96-well plate reader. For colony formation assay, 100-200 cells/well were seeded in 6-well plate and cultured for 24 hrs before IR treatment. The cells were then cultured for 10 days before fixation and staining with crystal violent (0.005% in 20% methanol). The colonies were counted manually. Both the fitted sigmoidal dose response curve and IC 50 were calculated using Graph Pad Prism Program.
Neutral comet assay. Neutral comet assay was performed using a kit from Trevigen (Gaithersburg, MD) according to the manufacturer's instructions. Briefly, cells were harvested at different times following IR and single cell suspensions in PBS at 1×10 5 cells/ml were mixed with low temperature-melting agarose at 37°C and layered onto comet slides.
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The agarose on slides was allowed to solidify for 1 hour at 4°C, incubated in a pre-chilled lysis solution for 30 min at 4°C in the dark, and subjected to electrophoresis. The slides were then immersed twice in distilled water for 10 min, once in 70% ethanol for 5 min, dried completely at room temperature and stained with SYBR Green I (Trevigen). Comets were viewed and recorded using a Zeiss Axiovert 25 fluorescent microscope equipped with a camera and analyzed with CometScore V1.5 (TriTek, Sumerduck, VA). The Olive Tail
Moment was determined by scoring at least 100 cells in each sample (17) . was achieved by HindIII digestion between CMV promoter and the luciferase gene and verified using agarose gel electrophoresis. Cells were harvested at 6 hrs after transfection and both the firefly and renilla luciferase activities were determined using a Dual-Luciferase
Reporter Assay System on a luminometer. Relative NHEJ activity = F. Luc linear ×100%/ F.
Host cell reactivation-based HR assay was performed using a kit following manufacturer's instructions (Norgen Biotek Corp). Briefly, two different deletion mutants (dl-1 and dl-2) were engineered form the same parental reporter plasmid and transfected into cells individually or in combination. At 24 hrs after transfection, the reporter plasmids were recovered from these cells and used as template for real-time PCR analysis of production of wild type plasmid from HR reaction.
Real-time RT-PCR.
Firstly, total RNAs were extracted from 1×10 7 fresh cells using the RNeasy Mini Kit (Qiagen) following the manufacturer's protocol. All RNA samples were treated with RNase-free DNase I (Promega) and quantified using a Nanodrop spectrophotometer (Fisher Scientific). For reverse transcription, 1 µg DNA-free RNA was used for cDNA synthesis using iScript cDNA synthesis kit (Bio-Rad) following the manufacturer's protocol exactly without any modification.
Real-time RT-PCR was performed using SYBR Green PCR master mix as previously described (Applied Biosystems) (21) . Relative mRNA levels were quantified using the 8 comparative Ct method by normalizing to the endogenous reference gene GAPDH and given by 2 ∆∆Ct where ∆Ct=Ct (target gene) -Ct (GAPDH) and ∆∆Ct=∆Ct (test sample) -∆Ct (control sample) . Three independent experiments were performed with each in triplicate determinations.
Supplemental Table S2 shows the primer sequences, which have been used to blast nucleotide database and no gene other than the targeted ones were found.
Subcellular fractionation. Subcellular fractionation was performed as previously described (22, 23) . Briefly, cells were harvested, washed with PBS, and lysed in buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl 2 , 0.34 M sucrose, 10% glycerol, 1 mM DTT and 2 mM PMSF) containing 0.1% Triton X-100 on ice for 10 min followed by centrifugation (1,300×g for 5 min at 4°C) to collect crude nuclei fraction (pellet). The supernatant was subjected to high-speed centrifugation (20,000×g for 5 min at 4°C) to collect the supernatant (cytosolic fraction). The low-speed pellet was subjected to lysis in buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT and 2 mM PMSF) on ice for 30 min followed by centrifugation (1,700×g for 5 min at 4°C) to separate soluble nuclear (supernatant) and chromatin-bound (pellet) fractions.
Pulse labeling. Pulse labeling was performed as previously described (24) . Briefly, 6×10 5 cells were seeded in 10-cm dish and cultured for 72 hrs. The cells were washed twice with PBS and once with RPMI1640 lacking methionine followed by incubation for 2 hrs in the same medium supplemented with 75 μCi/ml [ 35 S]methionine. The labeled cells were then washed with PBS and harvested for lysate preparation and immunoprecipitation as described above. The immunoprecipitated proteins were separated by SDS-PAGE and signals of newly synthesized proteins were captured using X-ray films.
Cell cycle analysis. Cell cycle analysis was performed as previously described (25) .
Briefly, 2×10 5 cells were seeded in 6-well plates followed by IR treatment. Cells were 9 collected at different times, fixed in cold 75% ethanol and stained with 50 μg/ml PI followed by analysis with FACS.
RESULTS
14-3-3σ contributes to cellular resistance to DNA-damaging drugs and IR.
To determine the role of 14-3-3σ in cellular response to DNA-damaging drugs and IR, we took advantage of the previously established stable cell lines MiaPaCa-2/σ with over-expression of ectopic 14-3-3σ and BxPC-3/Sh-σ with knockdown of endogenous 14-3-3σ ( Figure 1A ). The parental BxPC-3 cells express high levels of endogenous 14-3-3σ, equivalent to that in human pancreatic cancer tissues (2) while MiaPaCa-2 cells lack endogenous 14-3-3σ (2), which are good models for knockdown and over-expression studies, respectively. Firstly, we subjected these cells to MTT survival assay following treatments with gemcitabine, mitoxantrone, or doxorubicin. As shown in Figure 1B , MiaPaCa-2/σ cells are significantly more resistant than the control vector-transfected MiaPaCa-2/Vec cells. Consistently, the stable BxPC-3/Sh-σ cells are significantly more sensitive to these drugs than the control BxPC-3/Scr cells. We next tested their response to IR treatments using colony formation survival assay. As shown in Figure 1C and supplemental Figure S1 , higher expression level of 14-3-3σ also significantly increased cellular tolerance of IR.
We also tested another cell line, H1299 that expresses little endogenous 14-3-3σ (26), by stably over-expressing ectopic 14-3-3σ (H1299/σ) ( Figure S2A ). As shown in Figure S2B , H1299/σ was more resistant to IR than the control H1299/Vec cells. These studies suggest that 14-3-3σ contributes to cellular resistance to DNA-damaging drugs and IR in different human cancer cells. To further determine the role of 14-3-3σ in removing DNA damages, we performed neutral comet assay following IR. As shown in Figure 2E 14-3-3σ promotes NHEJ repair of DSBs. To assess directly if 14-3-3σ increases repair of IR-induced DSBs, we first examined the effect of 14-3-3σ on NHEJ activity by performing a host-cell-reactivation-based NHEJ assay in these cells. As shown in Figure 3A , cells expressing high levels of ectopic (MiaPaCa-2/σ) or endogenous (BxPC-3/Scr) 14-3-3σ had 2-3 fold higher NHEJ activity than the cells expressing little or no 14-3-3σ (BxPC-3/Sh-σ and MiaPaCa-2/Vec). Similarly, NHEJ repair activity was also significantly increased in H1299/σ cells compared with the control H1299/Vec cell ( Figure S4A ). However, 14-3-3σ may not affect HR repair as determined using host-cell-reactivation-based HR assay of the BxPC-3/Sh-σ and BxPC-3/Scr cell pair ( Figure S4B ). Interestingly, HR repair was significantly increased in H1299/σ cells compared with the control H1299/Vec cell ( Figure S4C ). Thus, 14-3-3σ positively regulates the NHEJ repair of DSBs and also possibly HR but in a cell linedependent manner.
14-3-3σ modulates γ-H2AX
14-3-3σ promotes recruitment of DNA-PKcs. Because 14-3-3σ regulation of HR repair appears to be cell line-dependent, we decided to focus on NHEJ in the following studies. To understand the mechanism of 14-3-3σ action in regulating NHEJ, we first tested its effect on the expression of genes in the DNA-PK complex, Ku70, Ku80, and DNA-PKcs, which plays an important role in NHEJ. As shown in Figure 3B , 14-3-3σ had no discernible effect on the total level of Ku70, Ku80 and DNA-PKcs. Next, we determined the effect of 14-3-3σ on recruitment of the DNA-PK complex onto damaged chromatin following IR. For this purpose, we first isolated cytosolic, soluble nuclear and chromatin-bound proteins followed
by Western blot analysis of Ku70, Ku80, and DNA-PKcs in these fractions. As shown in Figure 3C , the cells expressing high levels of 14-3-3σ (MiaPaCa-2/σ and BxPC-3/Scr) enhanced both the basal and IR-induced recruitment of DNA-PKcs to chromatin compared with the cells expressing little 14-3-3σ (MiaPaCa-2/Vec and BxPC-3/Sh-σ). However, the recruitment of Ku70 and Ku80 was not affected by altering 14-3-3σ expression. Thus, 14-3-3σ regulates NHEJ repair of DSBs possibly by promoting recruitment of DNA-PKcs to the damaged DNAs.
PARP1 mediates 14-3-3σ regulation of NHEJ. It has been reported that PARP1
participates in the NHEJ repair pathway (27) by PARylating and recruiting DNA-PK proteins (28) . To test the possible role of PARP1 in mediating 14-3-3σ regulation of DNA-PKcs recruitment, we first determined if 14-3-3σ regulates PARP1 expression by testing the stable BxPC-3/Sh-σ and MiaPaCa-2/σ cells in comparison with their respective control cells using
Western blot and real-time RT-PCR analysis. As shown in Figure 4A -B, BxPC-3/Sh-σ had reduced while MiaPaCa-2/σ had increased levels of PARP1 protein and mRNA compared with their respective control cells. Transient 14-3-3σ knockdown in BxPC-3 cells using two different shRNAs or a siRNA pool as describe previously (4) also successfully reduced PARP1 expression ( Figure 4C ).
The altered transcription of PARP1 by 14-3-3σ likely resulted in altered synthesis of PARP1 and change in PARP1 protein level. To test this possibility, we performed a pulselabeling experiment in combination with immunoprecipitation of PARP1 followed by separation on SDS-PAGE and autoradiography. As shown in Figure 4D , indeed PARP1
protein synthesis was dramatically decreased in BxPC-3/Sh-σ cells and dramatically increased in MiaPaCa-2/σ cells compared with their respective control cells. Thus, 14-3-3σ
regulates PARP1 expression, which in turn contributes to NHEJ repair of DSBs. However, it is noteworthy that the effect of 14-3-3σ on PARP1 appears to be more dramatic as determined using pulse labeling ( Figure 4D Next, we determined the effect of PARP1 knockdown on NHEJ. As shown in Figure   5A , PARP1 knockdown in BxPC-3 cells using two different siRNAs had not effect on the expression of DNA-PKcs or 14-3-3σ. However, the knockdown significantly reduced NHEJ activity ( Figure 5B ) and recruitment of DNA-PKcs to chromatin ( Figure 5C ). Consistently, PARP1 knockdown in MiaPaCa-2/σ cells with overexpression of ectopic 14-3-3σ using the same siRNA had not effect on the expression of DNA-PKcs or 14-3-3σ ( Figure S5A ), but reduced DNA-PKcs recruitment in these cells ( Figure S5B ). Thus, it is possible that PARP1 mediates 14-3-3σ regulation of DNA-PKcs recruitment. 
14-3-3σ inhibits IR-induced apoptosis.
14-3-3σ regulation of Chk2 expression in G2/M arrest for NHEJ repair. Previously, it
has been suggested that 14-3-3σ plays an important role in regulating cell cycle and help arrest cells in G2/M phase following DNA damage to allow efficient repair of the DNA 14 damages and to prevent mitotic catastrophe and apoptosis (29, 30) . Others and we have also shown that 14-3-3σ helps arrest cells in G2/M phase following DNA-damages (9, 11, 25) . To determine how 14-3-3σ regulates cell cycle progression, we first analyzed cell cycle distribution of MiaPaCa-2/σ and BxPC-3/Sh-σ cells in comparison with their respective control cells following IR. As shown in Figure 7A To investigate how 14-3-3σ regulates G2/M arrest in response to IR, we determined the potential effect of 14-3-3σ on the expression of Chk2, which regulates several downstream effector molecules that are known ligand substrates of 14-3-3 proteins (12) and important for cell cycle progression following DNA damage (31) . As shown in Figure 7C , Chk2 expression is up-regulated in MiaPaCa-2/σ and down-regulated in BxPC-3/Sh-σ cells compared with their respective control MiaPaCa-2/Vec and BxPC-3/Scr cells as determined using Western blot. Real-time RT-PCR analysis showed that the Chk2 mRNA is also increased in MiaPaCa-2/σ cells and decreased in BxPC-3/Sh-σ cells ( Figure 7D ). Similar findings were also observed with H1299/σ and H1299/Vec cell pair ( Figure S6 ). Thus, 14-3-3σ likely up-regulates Chk2 expression in addition to up-regulating PARP1 expression.
To determine if Chk2 potentially mediates 14-3-3σ function in G2/M arrest following DNA damage, we first knocked known Chk2 expression in MiaPaCa-2/σ and MiaPaCa-2/Vec cells using three different siRNAs followed by treatment with IR before determining 15 cell cycle distribution. As shown in Figure 7E -F, siRNA1 had no effect on Chk2 expression while siRNA#2 and siRNA#3 significantly knocked down Chk2 expression with different efficiency with siRNA#2 most effective, which was chosen for further study. As shown in Figure 7G , the scrambled siRNA-transfected MiaPaCa-2/σ cells have more G2/M population than MiaPaCa-2/Vec cells with or without IR treatment, consistent with the data shown in Figure 7B . However, Chk2 knockdown in MiaPaCa-2/σ cells eliminated the 14-3-3σ-induced increase in G2/M population. Thus, Chk2 may mediate 14-3-3σ-induced G2/M arrest following DNA damages.
To determine if 14-3-3σ-induced G2/M arrest enhances NHEJ repair of IR-induced DSB, we tested the effect of eliminating G2/M arrest by Chk2 knockdown on 14-3-3σ-induced NHEJ activity using the HCR assay as described above. As shown in Figure 7H , Chk2 knockdown in MiaPaCa-2/σ cells by siRNA#2 eliminated 14-3-3σ-induced NHEJ activity. It is also noteworthy that the siRNA#3 only slightly attenuated the 14-3-3σ-induced NHEJ activity, consistent with its lower activity in knocking down Chk2 expression ( Figure   7E -F). Thus, we conclude that 14-3-3σ up-regulates Chk2 expression to arrest cells at G2/M phase following DNA damage, which may contribute to 14-3-3σ-induced NHEJ repair of IRinduced DSBs.
14-3-3σ regulation of Chk2 may be via PARP1.
The above studies show that 14-3-3σ
regulates both Chk2 and PARP1 expression. To determine if these regulations are independent events or have a linear relationship, we tested Chk2 and PARP1 expressions following their knockdowns. As shown in Figure S7A , PARP1 knockdown in BxPC-3 cells led to reduced Chk2 expression. However, Chk2 knockdown had no effect on PARP1 expression ( Figure S7B ). Thus, 14-3-3σ regulation of Chk2 expression may be via regulating PARP1.
DISCUSSION
Efficient DNA repair is considered as one of the major mechanisms that contribute to chemo and radiation resistance. While 14-3-3σ has been suggested to contribute to these resistances by arresting cells in G2/M phase for repair of DNA damages, this hypothesis has not been tested previously. Here, we showed that 14-3-3σ contributed IR resistance possibly by regulating cell cycle progression and NHEJ repair of IR-induced DSBs via regulating the expression of Chk2 and PARP1. These findings not only illustrate the molecular mechanisms of 14-3-3σ action in chemo and radiation resistance but also suggest that 14-3-3σ may be an upstream master regulator in chemo and radiation resistance and cancer cell survival. It is also noteworthy that 14-3-3σ has been shown to contribute to cisplatin resistance (1).
Although the detailed mechanism for cisplatin resistance is unknown, it is tempting to speculate that 14-3-3σ may contribute to nucleotide excision repair of cisplatin-DNA adducts via NHEJ repair of DSB produced from these adducts.
The involvement of PARP1 in NHEJ repair (27) may be via PARylating and by increasing DNA-PKcs recruitment (28, (32) (33) (34) . Our finding that 14-3-3σ increase DNA-PKcs recruitment possibly via increasing PARP1 is consistent with these previous observations.
Interestingly, 14-3-3σ has no effect on the expression or recruitment of Ku proteins. It remains unknown if Ku proteins are abundantly bound to chromatin and if DNA-PKcs may serve as a limiting factor for NHEJ repair of DSBs in BxPC-3 and MiaPaCa-2 cells. However, it has been reported previously that increased Ku70 expression promotes cellular resistance to IR in human cancer cells (35) (36) (37) .
Previously, it has been suggested that 14-3-3σ binds to cdk2 and cdc25A, the downstream effectors of Chk2, and arrests them in cytoplasm, which results in G2/M arrest following DNA damages (38) (39) (40) . Together with our finding that 14-3-3σ up-regulates Chk2 expression, we conclude that 14-3-3σ may act at multiple points in regulating cell cycle progression in response to DNA damages.
Although we have shown here that 14-3-3σ contributes to IR resistance by arresting cancer cells in G2/M phase and by increasing NHEJ repair via up-regulating Chk2 and PARP1 expression, it remains to be determined how 14-3-3σ regulates the expression of these genes. The finding that the mRNA levels of Chk2 and PARP1 were altered by 14-3-3σ
suggests that 14-3-3σ may regulate the transcription of these genes. Although it has been shown that Chk2 expression is negatively regulated by p53 (41,42) and 14-3-3σ regulates p53 (43) , p53 in BxPC-3 cells is inactive due to mutation and, thus, may not mediate 14-3-3σ regulation of Chk2 expression in these cells. However, PARP1 may mediate 14-3-3σ regulation of Chk2 expression. Recently, we have shown that the PARP1 gene promoter contains a NF-κB-binding element and that NF-κB negatively regulates PARP1 expression in another cell line, Panc-1 (20) . It has also been shown that 14-3-3 proteins could bind to both p65 and IκBα and facilitate the nuclear export of IκBα-p65 complexes (44) . Therefore, it is tempting to speculate that 14-3-3σ may bind to and arrest p65 in the cytoplasm and, thus, blocks p65 negative regulation of PARP1 promoter activity, resulting in increased PARP1
expression, which in turn regulates Chk2 expression.
It is of interest to note that PARP1 is also a substrate of apoptosis executioner caspases while participating in NHEJ repair of DSBs. In this study, we showed that 14-3-3σ up-regulates PARP1 transcription and prevents PARP1 cleavage due to apoptosis. The role of 14-3-3σ in resisting apoptosis has previously been shown and possibly via binding to and arresting pro-apoptotic proteins (10,45). The inhibition in PARP1 cleavage due to inhibition of apoptosis and the increased PARP1 expression by 14-3-3σ may form a feed-forward loop of DNA repairs for cancer cell survival against DNA-damaging drug and radiation treatments.
Although both NHEJ and HR mechanisms are responsible for repair of DSBs, it appears that the 14-3-3σ regulation of DSB repair via HR is cell-line-dependent. 
